Ashvattha Therapeutics
Redwood City, CA
Ashvattha Therapeutics is a clinical-stage biopharmaceutical company focused on developing novel hydroxyl dendrimer (HD) therapeutics (HDTs) to treat unmet medical needs in oncology, ophthalmology, and inflammatory diseases.
avttx.comCompany Details
Founded
- 2015
Employees
- Between 20 - 50 employees
Raised
- $148,000,000
Headquarters Location
- Redwood City, CA
Public
- No
Acquired
- No
CEO
Jeffrey Cleland
Founders
- Rangaramanujam KannanJustin HanesSujatha KannanJeffrey Cleland
Company Collections
These are collections Ashvattha Therapeutics is a part of. Click on the collection name to view similar companies.
Ashvattha Therapeutics' Industries
Ashvattha Therapeutics Headquarters Location
1235 Radio Rd suite 200, Redwood City, CA 94065
Total Amount Raised: $148,000,000
Ashvattha Therapeutics Funding Rounds
Series B
$50,000,000
Series B Investors
Tribe CapitalNatural CapitalSeries B
$69,000,000
Series B Investors
Huadong MedicineNatural Capital Investment FundTribe CapitalPlum AlleyConvertible Note
$22,000,000
Convertible Note Investors
Natural CapitalSam AltmanPhilip DeutchBhaskar GhoshKyle WangKingsley AdvaniSakya DuvvuruHelios CapitalPlum AlleyTribe CapitalSand Hill AngelsZephyr Venture PartnersSeries A
$7,000,000
Series A Investors
Natural CapitalEcoR1 CapitalArjun Sethi
Funding info provided by Diffbot.
Ashvattha Therapeutics Reviews
0 out of 5 stars
Based on 0 reviews
Review data
Share your thoughts
Worked here? Share your experience. Help others decide if this company is right for them. Write a review on Ashvattha Therapeutics.